Navigation Links
MedAptus Secures $6 Million Investment
Date:3/19/2009

Funding to Support Increasing Sales of the Company's Innovative Revenue Cycle Offerings

BOSTON, March 19 /PRNewswire/ -- MedAptus(R), market leader for charge capture technologies, today announced that it has secured $6 million in capital in a financing led by existing investor Boston Millennia Partners. This investment will enable MedAptus to further support the growth of its Intelligent Charge Capture suite of products.

"The realities of today's economy require provider organizations to look at financial performance more closely than ever," said MedAptus CEO Dennis Mitchell. "This means that our offerings have become must-have for hospitals and physician practices in order to grow and thrive. This financing will allow us to innovate in ways that drive unparalleled revenue integrity and optimization for our customers."

MedAptus' powerful, yet easy-to-use, electronic charge capture technologies are practice-proven to maximize revenue, enhance compliance efforts and increase billing process transparency. Offerings include solutions for professional, facility and infusion services coding and billing, as well as complementary modules for PQRI and other clinically oriented tasks. Thousands of clinicians across organizations that include single-specialty practices, multi-specialty groups and large academic institutions use MedAptus on a daily basis.

"We are quite proud of the success MedAptus has experienced with its physician solution. Also, the company's Facility Charge Capture product, the first of its kind for the ambulatory environment, is a tremendously appealing product, particularly given the increasing economic challenges facing hospitals," said Robert Jevon, partner at Boston Millennia Partners and a member of the MedAptus Board of Directors. "Lots of people are talking about the inefficient processes that plague healthcare -- we're delighted that MedAptus is actually doing something about it."

About MedAptus

MedAptus is the Gold Standard in the healthcare revenue cycle for effective charge management, compliance and workflow efficiency. With the most powerful, yet easy-to-use, Intelligent Charge Capture technologies available, we enjoy enterprise-wide adoption at some of the nation's most prestigious healthcare organizations. Our portfolio of full-scale Professional and Facility offerings is practice-proven to increase revenue, re-engineer archaic processes, enhance EMR investments and save busy providers valuable time. For more information, visit http://www.medaptus.com or call 617.896.4000.

    MedAptus Contact:

    Jennifer Crowley
    p. 617.896.4030
    jcrowley@medaptus.com

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE MedAptus
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. MedAptus Experiences Record Growth of 70 Percent
2. MedAptus Selected by Kentucky Medical Services Foundation for Professional Charge Capture Technology
3. Dana-Farber Cancer Institute Completes Deployment of MedAptus Infusion Services Module
4. Still River Systems, Inc. Secures $33 Million in Private Financing
5. Solta Medical, Inc. Secures $9M Credit Facility from Silicon Valley Bank
6. Ranbaxy Secures Final FDA Approval for Quinapril Hydrochloride + Hydrochlorothiazide Tablets
7. Noteworthy Medical Systems, Inc. Secures Capital from Top European eHealth Provider and Closes on Merger with Strategic Partner
8. Phreesia Secures $11.6M Series C Funding Led by BlueCross BlueShield Venture Partners and Sandbox Industries
9. SpectraScience Secures Distribution for WavSTAT(R) Cancer Diagnosis System in Greece & Cyprus
10. Diagnosoft(R) Secures $4 Million in Financing and Appoints a New President and CEO
11. Stuart M. Goldstein, Southern New Jersey Patent and Intellectual Property Attorney, secures a New Revolutionary Eco-Friendly Patent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... 2016 , ... CURE Media Group, the nation’s leading digital and print media ... Lung Cancer in efforts to combat lung cancer, announced CURE Media Group President Michael ... Media Group is honored to team up with Upstage Lung Cancer in order to ...
(Date:12/8/2016)... ... ... With the increasing demand for dental implants, the National Association of Dental Laboratories ... and patients about the safety issues related to dental restorations. According to the American ... projected to reach $6.4 billion in 2018 with more than 30 million Americans missing ...
(Date:12/8/2016)... ... 2016 , ... David J. Dykeman , Ginger Pigott , and ... speak at DeviceTalks West, Dec. 12, 2016, at the Fairmont Newport Beach in California. ... firm’s global Life Sciences & Medical Technology Group have been featured speakers at every ...
(Date:12/8/2016)... ... ... Premier Fitness Camp (PFC) and The Chopra Center for Wellbeing announced today the ... their world headquarters of Omni La Costa Resort & Spa in San Diego. , ... loss, personal development, a healthy lifestyle, or mental and physical healing. The week-long wellness ...
(Date:12/8/2016)... ... December 08, 2016 , ... SunView ... customers and employees that are both engaging and easy to use. Coming off ... the software company revealed today its plans to roll out new AI-powered self-service ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... 2016 Bodycad announced it has been ... accuracy, reproducibility and speed for 3D constructs via ... bone orthopaedic applications. These patents are critical to ... restorations based on each patient,s distinct anatomy. ... harnesses the world,s first suite of orthopaedic CAD/CAM ...
(Date:12/8/2016)... 2016  Pennsylvania Physician General Dr. Rachel ... Programs Gary Tennis released safe prescribing ... benzodiazepines, developed with the help of a task ... are frequently prescribed for anxiety or insomnia," said ... opioid pain medications, benzodiazepines pose a significant risk ...
(Date:12/8/2016)... , Dec. 8, 2016  Valeant Pharmaceuticals ... TSX: VRX) ("Valeant") today announced positive results from ... study to assess the safety and efficacy of ... treatment of plaque psoriasis. Within ... with moderate to severe psoriasis, IDP-118 showed statistical ...
Breaking Medicine Technology: